Effects of levosimendan on indocyanine green plasma disappearance rate and the gastric mucosal-arterial pCO2 gradient in abdominal aortic aneurysm surgery

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 6, 2008, Pages 785-792

  Leppikangas, H ^a   Tenhunen, J J ^a   Lindgren, L ^a   Salenius, J P ^a   Ruokonen, E ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Blood flow; Calcium sensitizer; Gastrointestinal tract; Inotropy; Levosimendan; Splanchnic perfusion

Indexed keywords

BUPIVACAINE; CISATRACURIUM; DOBUTAMINE; FENTANYL; INDOCYANINE GREEN; LEVOSIMENDAN; NITROPRUSSIDE SODIUM; NORADRENALIN; PROPOFOL; VASOACTIVE AGENT;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; AORTA CLAMPING; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; FEMALE; HEART INDEX; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPLANCHNIC BLOOD FLOW; STOMACH BLOOD FLOW; STOMACH PRESSURE; SYSTEMIC CIRCULATION; TONOMETRY; TREATMENT OUTCOME;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD CIRCULATION; CARBON DIOXIDE; COLORING AGENTS; DOUBLE-BLIND METHOD; FEMALE; GASTRIC MUCOSA; HUMANS; HYDRAZONES; INDOCYANINE GREEN; MALE; MIDDLE AGED; NOREPINEPHRINE; PYRIDAZINES; SPLANCHNIC CIRCULATION; TIME FACTORS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 45149127573     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01659.x     Document Type: Article

References (31)

1. Mythen MG, Webb AR. Intra-operative gut mucosal hypoperfusion is assosiated with increased post-operative complications and cost. Intensive Care Med 1994 20 : 99 1042.
2. Syk I, Brunkwall J, Ivancev K et al. Postoperative fever, bowel ischemia and cytokine response to abdominal aortic aneurysm repair - a comparison between endovascular and open surgery. Eur J Vasc Endovasc Surg 1998 15 : 398 405.
3. Ghosh J, Khwaja N, Howarth V et al. Colonic epithelial apoptosis during conventional and endoluminal aortic surgery. Br J Surg 2005 92 : 443 8.
4. Nakatsuka M. Assessment of gut mucosal perfusion and colonic tissue blood flow during abdominal aortic surgery with gastric tonometry and laser doppler flowmetry. Vasc Endovasc Surg 2002 36 : 193 8.
5. Uusaro A, Ruokonen E, Takala J. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 1995 74 : 149 54.
6. Tenhunen JJ, Martikainen TJ, Uusaro A et al. Dopexamine reverses colonic but not gastric mucosal perfusion defects in lethal endotoxin shock. Br J Anaesth 2003 91 : 878 85.
7. Guarracino F, Cariello C, Danella A et al. Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy. Acta Anaesthesiol Scand 2007 51 : 1217 24.
8. Haikala H, Kaivola J, Nissinen E et al. Cardiac troponin C as a target protein for a novel calsium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995 27 : 1859 66.
9. Ukkonen H, Saraste M, Akkila J et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000 68 : 522 31.
10. Follath F, Cleland JG, Just H et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002 360 : 196 202.
11. Mebazaa A. The SURVival of Patients with Acute Heart Failure in Need if IntraVEnous Inotropic Support (SURVIVE) trial. Late-breaking Clinical Trials, 13-16 November 2005. American Heart Association, Annual Scientific Session. Dallas, TX.
12. Schwarte LA, Picker O, Bornstein SR et al. Levosimendan is superior to milrinone and dobutamine in selectively increasing mircrovascular gastric mucosal oxygenation in dogs. Crit Care Med 2005 33 : 135 42.
13. Pagel PS, Hettrick DA, Warltier DC. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol 1996 119 : 609 15.
14. Zager RA, Johnson AC, Lund S et al. Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 2006 290 : F1453 6.
15. Oldner A, Konrad D, Weitzberg E et al. Effects of levosimendan, a novel inotropic calsium-sensitizing drug, in experimental septic shock. Crit Care Med 2001 29 : 2185 93.
16. Dubin A, Murias G, Sottile JP et al. Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 2007 33 : 485 94.
17. Lilleberg J, Nieminen MS, Akkila J et al. Effects of a new calcium sensitizer, levosimendan, on hemodynamics, coronary blood flow and myocardial substrate utilization early after coronary bypass grafting. Eur Heart J 1998 19 : 660 8.
18. Morelli A, De Castro S, Teboul J-L et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005 31 : 638 44.
19. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000 2 : 1301 8.
20. Kuntz HD, Schregel W. Indocyanine green: evaluation of liver function - application in intensive care medicine. In : Lewis FR, Pfeiffer UJ, eds. Fiberoptics in critical care monitoring. Berlin Heidelberg NY : Springer, 1990 : 57 62.
21. Sakka S, Reinhart K, Meier-Hellmann A. Comparison of invasive and non-invasive measurements of indosyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable heamodynamics. Intensive Care Med 2001 26 : 1553 6.
22. Sakka S, Koeck H, Meier-Hellmann A. Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med 2004 30 : 506 9.
23. Uusaro A, Ruokonen E, Takala J. Estimation of splanchnic blood flow by Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res 1995 30 : 106 12.
24. Parviainen I, Väisänen O, Ruokonen E et al. Effect of nasogastric suction and ranitidine on the calculated gastric mucosal pH. Intensive Care Med 1996 22 : 319 23.
25. 2 gradients? Br J Anaesth 1999 83 : 740 6.
26. Hiltebrand LB, Krejci V, Banic A et al. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Critical Care Med 2000 28 : 3233 41.
27. Tenhunen JJ, Uusaro A, Karja V et al. Apparent heterogeneity of regional blood flow and metabolic changes within splanchnic tissues during experimental endotoxin shock. Anesth Analg 2003 97 : 555 63.
28. Wiengand BD, Ketterer SG, Rapaport E. The use of indocyanine green for the evaluation of hepatic function and blood flow in man. Am J Dig Dis 1960 5 : 427 36.
29. Kholoussy AM, Pollack D, Matsumoto T. Prognostic significance of indocyanine green clearance in critically ill surgical patients. Crit Care Med 1984 12 : 115 6.
30. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002 122 : 1715 20.
31. Stehr A, Ploner F, Traeger K et al. Plasma disappearance of indocuanine green: a marker for excretory liver function? Intensive Care Med 2005 31 : 1719 22.